Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05403346 · ClinicalTrials.gov registry record
Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™)
A clinical trial, sponsored by Lumos Diagnostics.
- Terminated
- Registry status
- 45
- Enrollment target
NCT05403346 is a clinical trial that was terminated before completion, run by Lumos Diagnostics. The registered enrollment target is 45 participants.
The verdict
NCT05403346 was terminated before completion, sponsored by Lumos Diagnostics.
- TERMINATED
- Registry status
- 45 participants
- Enrollment target
Study Summary
Prospective study that will evaluate the clinical agreement of the CoviDx™ Self test compared to SARS-CoV-2 RT-PCR.
Interventions
- DEVICE CoviDx™ Covid-19 Antigen Self-Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-05-17 |
| Est. Completion | 2022-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05403346
The ClinicalTrials.gov registry entry for NCT05403346 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumos Diagnostics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CoviDx™ Covid-19 Antigen Self-Test is the first listed.
NCT05403346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05403346 about?
NCT05403346 is a clinical study titled "Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™)". Prospective study that will evaluate the clinical agreement of the CoviDx™ Self test compared to SARS-CoV-2 RT-PCR.
What is the current status of trial NCT05403346?
This trial is currently terminated. The enrollment target is 45 participants. The study started on 2022-05-17. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT05403346?
The interventions under investigation include: CoviDx™ Covid-19 Antigen Self-Test (DEVICE).
Who is sponsoring clinical trial NCT05403346?
This trial is sponsored by Lumos Diagnostics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.